-
Telephone:400-882-7987
-
wechat:15523376158wechat:15950040099
Contact Information
Monday to Friday 9:00-18:00

Sweep
In‑house‑built proprietary platform
First domestic offering for external services
Short assay turnaround time
Automated high‑throughput experimental system
Minimal background interference
Superior detection sensitivity
Data visualization capability
Traceable quality system
Rich project references
Support for CDE & FDA regulatory submissions
Benchmark against in‑vivo action profiles of real‑world drugs
Completed off‑target studies of multiple marketed mAbs
Case references covering camrelizumab, rituximab, etc.
Identify drug off‑target risks at pre‑research stage
Proactively mitigate potential safety concerns
Reduce investment risks in R&D and clinical phases